Mykotoxine – Bestimmung von Aflatoxinen, Ochratoxin A, freiem Ochratoxin α, Gliotoxin, Citrinin und Dihydrocitrinon in Urin mittels LC-MS/MS

Biomonitoring-Methode

Marion Berger¹ (Methodenentwicklung)
Max Deharde¹ (Methodenentwicklung)
Judith Neuhoff¹ (Methodenentwicklung)
Bernhard Monien² (Methodenprüfung)
Solveigh Siodlaczek² (Methodenprüfung)
  Thomas Göen³ (Leitung der Arbeitsgruppe „Analysen in biologischem Material“ der Ständigen Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe, Deutsche Forschungsgemeinschaft)
  Andrea Hartwig⁴ (Vorsitz der Ständigen Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe, Deutsche Forschungsgemeinschaft)
  MAK Commission<sup>5

1</sup> Bundesanstalt für Arbeitsschutz und Arbeitsmedizin (BAuA), Fachbereich 4 – Gefahrstoffe und biologische Arbeitsstoffe, Gruppe 4.2 – Medizinischer Arbeitsschutz, Biomonitoring, Nöldnerstraße 40/42, 10317 Berlin, Deutschland
² Bundesinstitut für Risikobewertung, Fachgruppe 54 – Abt. Lebensmittelsicherheit, Max-Dohrn-Straße 8–10, 10589 Berlin, Deutschland
³ Friedrich-Alexander-Universität Erlangen-Nürnberg, Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin, Henkestraße 9–11, 91054 Erlangen, Deutschland
⁴ Institut für Angewandte Biowissenschaften, Abteilung Lebensmittelchemie und Toxikologie, Karlsruher Institut für Technologie (KIT), Adenauerring 20a, Geb. 50.41, 76131 Karlsruhe, Deutschland
⁵ Ständige Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe, Deutsche Forschungsgemeinschaft, Kennedyallee 40, 53175 Bonn, Deutschland

Abstract

The working group “Analyses in Biological Materials” of the German Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission) developed and verified the presented biomonitoring method. The aim of this method is the selective and sensitive quantitation of aflatoxins (aflatoxins B1, B2, G1, G2, M1), ochratoxin A (OTA), free ochratoxin α (OTα), gliotoxin (GT), citrinin (CIT) and dihydrocitrinone (DH-CIT) in urine. Sample preparation comprises enrichment and purification of the analytes by solid-phase extraction using OASIS HLB cartridges. Calibration is performed with comparative standards prepared in pooled urine and treated analogously to the samples to be analysed. The aflatoxins, OTA, CIT, and DH-CIT are quantified using isotope-labelled internal standards (ISTDs), whereas OTα and GT are quantified without an ISTD. Determination is carried out by high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS). The method provides reliable and accurate analytical results, as shown by the good precision data with standard deviations below 9% for the aflatoxins, OTα, GT and CIT, below 13% for OTA, and below 20% for DH-CIT. Good accuracy data were obtained with mean relative recoveries in the range of 93–107% for the aflatoxins, OTα, GT and CIT, in the range of 83–103% for OTA, and in the range of 81–108% for DH-CIT. The method is both selective and sensitive, and has quantitation limits in the range of 0.013–0.022 μg/l for the aflatoxins and OTA and a quantitation limit of 1.0 μg/l for OTα, 1.5 μg/l for GT, 0.0075 μg/l for CIT, and 0.01 μg/l for DH-CIT.

---